Q2 2026 Holdings
Filed 2026-08-14 | 10 holdings | $185.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $54.1M | 1,822,150 | 29.1% |
| Nuvation Bio Inc.(NUVB) | Common Stock Class A | 67080N101 | $45.9M | 8,081,089 | 24.7% |
| Kestra Med Technologies Ltd(KMTS) | Common Stock | G52441105 | $26.0M | 1,022,149 | 14.0% |
| BridgeBio Oncology Therapeutics Inc.(BBOT) | Common Stock | 107924102 | $25.1M | 3,289,661 | 13.5% |
| Beta Bionics Inc.(BBNX) | Common Stock | 08659B102 | $20.6M | 1,316,183 | 11.1% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $6.8M | 241,255 | 3.7% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $2.9M | 843,750 | 1.6% |
| ImageneBio, Inc.(IMA) | Common Stock | 45175G207 | $2.7M | 455,361 | 1.4% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $1.5M | 876,357 | 0.8% |
| Odyssey Therapeutics Inc.(ODTX) | Common Stock | 67613T104 | $54.1K | 2,893 | 0.0% |